Wockhardt

Wockhardt is a global pharmaceutical and biotechnology company that has its headquarters in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France, and the US, and subsidiaries in various parts of the world.

History

Wockhardt was founded in 1960 by Habil Khorakiwala as a small pharmaceutical company. Over the years, it has grown into a multinational corporation with a diverse portfolio of products in the healthcare sector.

Business Operations

Wockhardt's business operations are divided into three main segments: Pharmaceuticals, Biopharmaceuticals, and Vaccines. The company's pharmaceutical division produces a wide range of generic and branded drugs for various therapeutic areas such as cardiology, diabetes, neurology, and gastroenterology. The biopharmaceutical division focuses on the development and production of biologic drugs, including biosimilars. The vaccines division is involved in the research, development, and production of vaccines for various infectious diseases.

Research and Development

Wockhardt has a strong focus on research and development (R&D), with several R&D centers in India and the UK. The company's R&D efforts are primarily focused on the development of new drugs and therapies, particularly in the areas of anti-infectives, biopharmaceuticals, and vaccines.

Regulatory Issues

In the past, Wockhardt has faced regulatory issues with the U.S. Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA). These issues have primarily related to manufacturing practices at some of the company's facilities.

See Also

• Pharmaceutical industry in India
• List of pharmaceutical companies

External Links

• Official Website

‎